Commentary
Commentary
A teenage girl refuses more cancer treatment; her father disagrees
For those who have recurrent disease and now face only experimental options – if they say no, that’s something we really have to listen to very...
Commentary
The surprising occupations with higher-than-expected ovarian cancer rates
This is how these types of studies work; they tend to raise more questions than they answer.
Commentary
Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS:Review of the Evidence
Background: There are currently no disease-modifying therapies (DMTs) on the market approved for nonactive secondary...
Commentary
Fireworks, Veterans, and PTSD: The Ironies of the Fourth of July
When I was a child, every Fourth of July holiday my father would take me to the military fireworks display at Fort Sam...
Commentary
Tirzepatide: Therapeutic titan or costly cure?
Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an...
Commentary
Beta cells from stem cells: Nearing a cure for type 1 diabetes?
The patients were producing insulin, they had positive C-peptide levels, and it showed that these beta cells work when given to human beings.
Commentary
New DEA CME mandate affects 2 million prescribers
One should not underestimate the sweeping scope of this new federal requirement.
Commentary
The most important question in medicine
“What else could this be?”
Commentary
Does ‘skeletal age’ describe fracture impact on mortality?
Mortality risk may be related to patients not fully understanding the consequence of a fragility fracture.
Commentary
DDW 2023: Common GI conditions in primary care
Gastroenterologist Vivek Kaul reviews important new studies relevant to primary care.